Literature DB >> 26299068

Survival and Prognostic Analysis of Primary Nasopharyngeal Carcinoma in North China.

Yanli Qu, Yanzhi Chen, Hong Yu, Yuxia Zhao, Guanoun Chen, Lu Bai, Dan Liu, Hongxin Su, Hetong Wang.   

Abstract

BACKGROUND: To investigate the prognostic factors of Nasopharyngeal Carcinoma (NPC).
METHODS: Retrospective analysis was carried out on the clinical data collected from three hospitals in North China between September, 1999 to March, 2012.
RESULTS: Higher survival rates (1, 3, 5, and 10 year) were found in NPC patients who were female, non-smokers, early clinical phase, and T1-2 (p < 0.05). No association was found between survival rates and drinking habits, lesion location, pathological types, N stages, and radiotherapy pattern. The 1-, 3-, and 5-year overall survival rates were equal following both conventional radiotherapy and Intensity-Modulating Radiotherapy (IMRT).
CONCLUSIONS: Patient gender, age, smoking status, clinical stages, and T stages all served as prognostic factors of nasopharyngeal carcinoma.

Entities:  

Mesh:

Year:  2015        PMID: 26299068     DOI: 10.7754/clin.lab.2014.141234

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  4 in total

1.  The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.

Authors:  Wang Zhi-Qiang; Mei Qi; Li Ji-Bin; You Rui; Liu You-Ping; Sun Rui; Hu Guang-Yuan; Chen Ming-Yuan; Hua Yi-Jun
Journal:  BMC Cancer       Date:  2019-11-19       Impact factor: 4.430

2.  Blood Cadmium Level Is Associated with Short Progression-Free Survival in Nasopharyngeal Carcinoma.

Authors:  Taifeng Du; Wenlong Huang; Shukai Zheng; Mian Bao; Yuanni Huang; Anna Li; Meirong He; Kusheng Wu
Journal:  Int J Environ Res Public Health       Date:  2019-08-16       Impact factor: 3.390

3.  Development and Validation of a Prognostic Nomogram Based on Residual Tumor in Patients With Nondisseminated Nasopharyngeal Carcinoma.

Authors:  Ping-Yan Liao; Zhong-Yi Dong; Chan-Tao Huang; Xin-Ran Tang; Guan-Dong Liu; De-Hua Wu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.

Authors:  H M Li; P Li; Y J Qian; X Wu; L Xie; F Wang; H Zhang; L Liu
Journal:  BMC Cancer       Date:  2016-12-13       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.